NM_020376.4:c.1327C>G
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_020376.4(PNPLA2):āc.1327C>Gā(p.Leu443Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000362 in 1,597,054 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020376.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00188 AC: 286AN: 152164Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000392 AC: 86AN: 219204Hom.: 0 AF XY: 0.000328 AC XY: 40AN XY: 121834
GnomAD4 exome AF: 0.000203 AC: 293AN: 1444782Hom.: 3 Cov.: 41 AF XY: 0.000156 AC XY: 112AN XY: 719024
GnomAD4 genome AF: 0.00187 AC: 285AN: 152272Hom.: 0 Cov.: 33 AF XY: 0.00197 AC XY: 147AN XY: 74442
ClinVar
Submissions by phenotype
Neutral lipid storage myopathy Benign:2
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
- -
Inborn genetic diseases Uncertain:1
The c.1327C>G (p.L443V) alteration is located in exon 10 (coding exon 9) of the PNPLA2 gene. This alteration results from a C to G substitution at nucleotide position 1327, causing the leucine (L) at amino acid position 443 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not specified Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at